| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiology | 37 | 2018 | 472 | 8.480 |
Why?
|
| Heart Defects, Congenital | 74 | 2019 | 1806 | 6.090 |
Why?
|
| Pediatrics | 22 | 2016 | 1141 | 4.040 |
Why?
|
| Periodicals as Topic | 11 | 2018 | 195 | 3.520 |
Why?
|
| Biomedical Research | 12 | 2017 | 518 | 2.930 |
Why?
|
| Congresses as Topic | 7 | 2015 | 170 | 1.760 |
Why?
|
| Editorial Policies | 7 | 2017 | 52 | 1.530 |
Why?
|
| Cardiac Surgical Procedures | 11 | 2019 | 1099 | 1.430 |
Why?
|
| Continuity of Patient Care | 6 | 2014 | 154 | 1.370 |
Why?
|
| Societies, Medical | 6 | 2015 | 678 | 1.120 |
Why?
|
| Hyperlipoproteinemia Type II | 3 | 2019 | 84 | 1.080 |
Why?
|
| Fellowships and Scholarships | 4 | 2013 | 271 | 1.020 |
Why?
|
| Heart Diseases | 8 | 2015 | 482 | 1.000 |
Why?
|
| Education, Medical, Graduate | 7 | 2014 | 507 | 0.970 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2011 | 122 | 0.970 |
Why?
|
| Quality of Health Care | 4 | 2011 | 391 | 0.920 |
Why?
|
| Humans | 185 | 2019 | 123223 | 0.920 |
Why?
|
| Liver Transplantation | 3 | 2019 | 1014 | 0.900 |
Why?
|
| Cholesterol | 5 | 2014 | 525 | 0.850 |
Why?
|
| Dyslipidemias | 2 | 2018 | 229 | 0.830 |
Why?
|
| Cardiology Service, Hospital | 3 | 2014 | 15 | 0.830 |
Why?
|
| Lipids | 2 | 2018 | 515 | 0.810 |
Why?
|
| Life Style | 4 | 2018 | 402 | 0.800 |
Why?
|
| Cardiac Catheterization | 19 | 2019 | 631 | 0.770 |
Why?
|
| Mentors | 2 | 2014 | 144 | 0.760 |
Why?
|
| Career Choice | 3 | 2016 | 143 | 0.750 |
Why?
|
| Thoracic Surgery | 2 | 2017 | 157 | 0.740 |
Why?
|
| Risk Reduction Behavior | 4 | 2016 | 135 | 0.740 |
Why?
|
| Education, Medical | 4 | 2014 | 285 | 0.740 |
Why?
|
| Age Factors | 19 | 2019 | 2802 | 0.720 |
Why?
|
| Hospitals, Pediatric | 5 | 2018 | 779 | 0.700 |
Why?
|
| Heart Septal Defects, Atrial | 8 | 2011 | 122 | 0.660 |
Why?
|
| Internship and Residency | 4 | 2016 | 1158 | 0.640 |
Why?
|
| Education, Medical, Continuing | 2 | 2016 | 138 | 0.640 |
Why?
|
| Forecasting | 7 | 2018 | 354 | 0.620 |
Why?
|
| Hypercholesterolemia | 6 | 2012 | 226 | 0.600 |
Why?
|
| United States | 26 | 2018 | 10637 | 0.590 |
Why?
|
| Heart Septal Defects, Ventricular | 8 | 2011 | 133 | 0.580 |
Why?
|
| Access to Information | 2 | 2015 | 41 | 0.580 |
Why?
|
| Life Change Events | 1 | 2018 | 59 | 0.580 |
Why?
|
| Child | 63 | 2018 | 24240 | 0.570 |
Why?
|
| Transition to Adult Care | 2 | 2018 | 119 | 0.540 |
Why?
|
| Adult | 77 | 2019 | 29072 | 0.540 |
Why?
|
| Exercise Therapy | 1 | 2018 | 150 | 0.520 |
Why?
|
| Steroid Metabolism, Inborn Errors | 1 | 2015 | 3 | 0.520 |
Why?
|
| Cholic Acids | 1 | 2015 | 16 | 0.520 |
Why?
|
| Hyperlipidemias | 3 | 2016 | 173 | 0.520 |
Why?
|
| Specialization | 1 | 2016 | 76 | 0.510 |
Why?
|
| Wolman Disease | 1 | 2015 | 7 | 0.500 |
Why?
|
| Coronary Artery Disease | 2 | 2019 | 746 | 0.480 |
Why?
|
| Practice Guidelines as Topic | 4 | 2015 | 1262 | 0.470 |
Why?
|
| Health Services Accessibility | 3 | 2010 | 594 | 0.460 |
Why?
|
| History, 21st Century | 5 | 2017 | 272 | 0.450 |
Why?
|
| Publishing | 1 | 2015 | 108 | 0.450 |
Why?
|
| History, 20th Century | 5 | 2017 | 383 | 0.440 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2013 | 78 | 0.420 |
Why?
|
| Pediatric Obesity | 2 | 2016 | 379 | 0.410 |
Why?
|
| American Heart Association | 2 | 2013 | 295 | 0.410 |
Why?
|
| Preventive Health Services | 1 | 2013 | 56 | 0.410 |
Why?
|
| Workload | 2 | 2013 | 146 | 0.400 |
Why?
|
| Atrial Fibrillation | 2 | 2010 | 624 | 0.400 |
Why?
|
| Risk Factors | 19 | 2019 | 10015 | 0.400 |
Why?
|
| Electrocardiography | 18 | 2012 | 958 | 0.400 |
Why?
|
| PubMed | 2 | 2010 | 21 | 0.390 |
Why?
|
| Information Dissemination | 2 | 2011 | 187 | 0.390 |
Why?
|
| Marfan Syndrome | 6 | 2003 | 137 | 0.380 |
Why?
|
| Codes of Ethics | 1 | 2011 | 7 | 0.380 |
Why?
|
| Time Factors | 17 | 2019 | 6221 | 0.370 |
Why?
|
| Marketing of Health Services | 1 | 2011 | 25 | 0.370 |
Why?
|
| Journal Impact Factor | 3 | 2018 | 22 | 0.370 |
Why?
|
| Speech | 1 | 2011 | 57 | 0.360 |
Why?
|
| Pulmonary Artery | 9 | 2008 | 439 | 0.360 |
Why?
|
| Interdisciplinary Communication | 2 | 2011 | 134 | 0.360 |
Why?
|
| Cardiac Care Facilities | 1 | 2010 | 8 | 0.350 |
Why?
|
| Diffusion of Innovation | 3 | 2016 | 97 | 0.350 |
Why?
|
| Heart Aneurysm | 2 | 2010 | 38 | 0.350 |
Why?
|
| Adolescent | 56 | 2018 | 19110 | 0.350 |
Why?
|
| Advisory Committees | 1 | 2011 | 148 | 0.350 |
Why?
|
| Ambulatory Care | 2 | 2014 | 377 | 0.340 |
Why?
|
| Perinatal Care | 1 | 2010 | 68 | 0.340 |
Why?
|
| Research Design | 1 | 2014 | 685 | 0.340 |
Why?
|
| Critical Pathways | 1 | 2010 | 68 | 0.340 |
Why?
|
| Patient Care Management | 1 | 2010 | 65 | 0.340 |
Why?
|
| Coronary Vessels | 5 | 2013 | 526 | 0.340 |
Why?
|
| Transposition of Great Vessels | 7 | 2005 | 132 | 0.340 |
Why?
|
| Mitral Valve | 4 | 2010 | 246 | 0.340 |
Why?
|
| Noonan Syndrome | 1 | 2010 | 29 | 0.340 |
Why?
|
| Physicians | 1 | 2016 | 584 | 0.330 |
Why?
|
| Atrial Appendage | 1 | 2010 | 43 | 0.330 |
Why?
|
| Abnormalities, Multiple | 4 | 2013 | 964 | 0.330 |
Why?
|
| Child, Preschool | 47 | 2019 | 13888 | 0.330 |
Why?
|
| Community Health Services | 1 | 2010 | 90 | 0.330 |
Why?
|
| Death, Sudden | 3 | 2008 | 45 | 0.320 |
Why?
|
| Patient Care Planning | 1 | 2010 | 123 | 0.320 |
Why?
|
| Aortic Diseases | 3 | 2008 | 196 | 0.320 |
Why?
|
| Health Services Research | 1 | 2010 | 186 | 0.320 |
Why?
|
| Infant | 47 | 2015 | 12349 | 0.320 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2008 | 127 | 0.320 |
Why?
|
| Treatment Outcome | 15 | 2014 | 12141 | 0.310 |
Why?
|
| Risk Assessment | 6 | 2016 | 3316 | 0.300 |
Why?
|
| Cardiovascular Diseases | 5 | 2016 | 1863 | 0.290 |
Why?
|
| Central Nervous System Stimulants | 1 | 2008 | 125 | 0.290 |
Why?
|
| Follow-Up Studies | 26 | 2018 | 5049 | 0.290 |
Why?
|
| Palliative Care | 4 | 2008 | 429 | 0.290 |
Why?
|
| Female | 89 | 2019 | 65549 | 0.290 |
Why?
|
| Coronary Stenosis | 1 | 2008 | 70 | 0.290 |
Why?
|
| Receptors, LDL | 2 | 2019 | 88 | 0.280 |
Why?
|
| Echocardiography | 21 | 2011 | 1049 | 0.280 |
Why?
|
| Coronary Disease | 7 | 1993 | 637 | 0.280 |
Why?
|
| Mitral Valve Stenosis | 3 | 2005 | 34 | 0.280 |
Why?
|
| Male | 80 | 2019 | 60117 | 0.280 |
Why?
|
| Coronary Vessel Anomalies | 8 | 2013 | 274 | 0.270 |
Why?
|
| Angioplasty, Balloon | 1 | 2008 | 161 | 0.270 |
Why?
|
| Organizational Objectives | 3 | 2011 | 33 | 0.270 |
Why?
|
| Mass Screening | 2 | 2012 | 788 | 0.260 |
Why?
|
| Cooperative Behavior | 3 | 2012 | 217 | 0.260 |
Why?
|
| Catheterization | 2 | 2005 | 235 | 0.260 |
Why?
|
| Angiography | 8 | 1988 | 215 | 0.260 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2008 | 216 | 0.260 |
Why?
|
| Balloon Occlusion | 1 | 2005 | 43 | 0.250 |
Why?
|
| Prognosis | 10 | 2018 | 4514 | 0.240 |
Why?
|
| Hospitalization | 2 | 2012 | 1726 | 0.240 |
Why?
|
| Subtraction Technique | 12 | 1988 | 36 | 0.240 |
Why?
|
| HIV Infections | 12 | 2003 | 1874 | 0.240 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2005 | 42 | 0.240 |
Why?
|
| Heart Ventricles | 10 | 2016 | 759 | 0.230 |
Why?
|
| Young Adult | 11 | 2019 | 8865 | 0.230 |
Why?
|
| Sports Medicine | 1 | 2004 | 28 | 0.230 |
Why?
|
| Texas | 5 | 2019 | 3560 | 0.230 |
Why?
|
| Cardiomegaly | 5 | 2001 | 133 | 0.220 |
Why?
|
| Patient Care Team | 4 | 2011 | 548 | 0.220 |
Why?
|
| Cause of Death | 6 | 2019 | 459 | 0.220 |
Why?
|
| Physical Examination | 1 | 2004 | 164 | 0.210 |
Why?
|
| Biomarkers | 4 | 2014 | 2946 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 1228 | 0.210 |
Why?
|
| Hypertension, Pulmonary | 9 | 2011 | 430 | 0.200 |
Why?
|
| Predictive Value of Tests | 6 | 2014 | 2112 | 0.200 |
Why?
|
| Clinical Competence | 5 | 2014 | 973 | 0.200 |
Why?
|
| Survival Rate | 8 | 2016 | 1996 | 0.200 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2004 | 247 | 0.200 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2001 | 10 | 0.200 |
Why?
|
| Stents | 1 | 2008 | 872 | 0.190 |
Why?
|
| Survivors | 2 | 2019 | 345 | 0.190 |
Why?
|
| Aortic Valve | 4 | 2000 | 432 | 0.190 |
Why?
|
| Obesity | 1 | 2013 | 2226 | 0.190 |
Why?
|
| Interpersonal Relations | 2 | 2014 | 225 | 0.190 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2011 | 138 | 0.180 |
Why?
|
| Hemodynamics | 8 | 2009 | 845 | 0.170 |
Why?
|
| Comorbidity | 5 | 2019 | 1496 | 0.160 |
Why?
|
| Health Services Needs and Demand | 2 | 2005 | 172 | 0.160 |
Why?
|
| Heterotaxy Syndrome | 1 | 2019 | 62 | 0.160 |
Why?
|
| Infectious Disease Transmission, Vertical | 6 | 2003 | 237 | 0.160 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2011 | 663 | 0.160 |
Why?
|
| Hypertension, Renovascular | 2 | 2018 | 29 | 0.160 |
Why?
|
| Arrhythmias, Cardiac | 6 | 2012 | 459 | 0.150 |
Why?
|
| Ventricular Function | 2 | 2018 | 92 | 0.150 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 2006 | 104 | 0.150 |
Why?
|
| Renal Artery Obstruction | 2 | 2018 | 41 | 0.150 |
Why?
|
| Retrospective Studies | 22 | 2019 | 16033 | 0.150 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2003 | 106 | 0.140 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2012 | 60 | 0.140 |
Why?
|
| Heart Failure | 6 | 2018 | 2127 | 0.140 |
Why?
|
| Patient Selection | 1 | 2000 | 685 | 0.140 |
Why?
|
| Health Status | 2 | 2019 | 374 | 0.140 |
Why?
|
| Infant, Newborn | 24 | 2005 | 8108 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2016 | 32 | 0.130 |
Why?
|
| Pedigree | 1 | 2019 | 1584 | 0.130 |
Why?
|
| Middle Aged | 35 | 2019 | 26016 | 0.130 |
Why?
|
| Pregnancy | 10 | 2010 | 7161 | 0.130 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2014 | 58 | 0.120 |
Why?
|
| Heart Block | 3 | 1992 | 40 | 0.120 |
Why?
|
| Equipment Design | 2 | 2009 | 601 | 0.120 |
Why?
|
| Curriculum | 2 | 2013 | 719 | 0.120 |
Why?
|
| Pulmonary Veins | 6 | 1989 | 162 | 0.120 |
Why?
|
| Attitude to Computers | 1 | 2015 | 49 | 0.120 |
Why?
|
| Interprofessional Relations | 3 | 2008 | 144 | 0.120 |
Why?
|
| Longitudinal Studies | 5 | 2014 | 1309 | 0.120 |
Why?
|
| Aorta, Thoracic | 4 | 2011 | 519 | 0.120 |
Why?
|
| Attitude of Health Personnel | 2 | 2012 | 641 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 3084 | 0.120 |
Why?
|
| Heart Valve Diseases | 4 | 1998 | 166 | 0.120 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2003 | 359 | 0.120 |
Why?
|
| Family Practice | 1 | 1994 | 90 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2012 | 826 | 0.110 |
Why?
|
| Peer Review | 1 | 2013 | 40 | 0.110 |
Why?
|
| Heart-Lung Transplantation | 1 | 1993 | 23 | 0.110 |
Why?
|
| Smoking | 2 | 2016 | 1031 | 0.110 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2005 | 238 | 0.110 |
Why?
|
| Health Resources | 1 | 2014 | 116 | 0.100 |
Why?
|
| Literature | 1 | 2012 | 6 | 0.100 |
Why?
|
| New Orleans | 1 | 2012 | 13 | 0.100 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 3670 | 0.100 |
Why?
|
| Hospital Mortality | 3 | 2014 | 1009 | 0.100 |
Why?
|
| Internet | 1 | 2015 | 378 | 0.100 |
Why?
|
| Phenotype | 2 | 2014 | 4228 | 0.100 |
Why?
|
| Homozygote | 1 | 2014 | 533 | 0.100 |
Why?
|
| Women's Health | 1 | 1993 | 132 | 0.100 |
Why?
|
| Heterozygote | 1 | 2014 | 672 | 0.100 |
Why?
|
| Takayasu Arteritis | 1 | 2011 | 13 | 0.100 |
Why?
|
| Travel | 1 | 2013 | 117 | 0.100 |
Why?
|
| Physician's Role | 2 | 2009 | 164 | 0.100 |
Why?
|
| Weight Gain | 1 | 2014 | 401 | 0.100 |
Why?
|
| Ventricular Function, Left | 3 | 2001 | 494 | 0.100 |
Why?
|
| Cyclonic Storms | 1 | 2012 | 76 | 0.090 |
Why?
|
| Global Health | 1 | 2016 | 557 | 0.090 |
Why?
|
| Disasters | 1 | 2012 | 99 | 0.090 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2012 | 73 | 0.090 |
Why?
|
| Warfarin | 1 | 2012 | 118 | 0.090 |
Why?
|
| Patient Admission | 2 | 2011 | 184 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 271 | 0.090 |
Why?
|
| Aged | 18 | 2014 | 19098 | 0.090 |
Why?
|
| Hospital Planning | 1 | 2010 | 3 | 0.090 |
Why?
|
| North America | 1 | 2011 | 239 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 3378 | 0.090 |
Why?
|
| Hypertension | 2 | 2016 | 1287 | 0.090 |
Why?
|
| DNA | 1 | 2015 | 1592 | 0.090 |
Why?
|
| Hypertension, Portal | 1 | 1991 | 78 | 0.090 |
Why?
|
| Health Care Rationing | 1 | 2010 | 58 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2011 | 427 | 0.080 |
Why?
|
| Health Care Reform | 1 | 2010 | 50 | 0.080 |
Why?
|
| Endovascular Procedures | 1 | 2018 | 728 | 0.080 |
Why?
|
| Anticoagulants | 2 | 2012 | 581 | 0.080 |
Why?
|
| Aortic Valve Stenosis | 2 | 1997 | 329 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2014 | 714 | 0.080 |
Why?
|
| Canada | 1 | 2010 | 296 | 0.080 |
Why?
|
| Lung Transplantation | 1 | 1993 | 316 | 0.080 |
Why?
|
| Heart Valve Prosthesis | 1 | 1992 | 293 | 0.080 |
Why?
|
| Program Development | 1 | 2010 | 190 | 0.080 |
Why?
|
| Family Relations | 1 | 2009 | 69 | 0.080 |
Why?
|
| Angiocardiography | 5 | 1986 | 13 | 0.080 |
Why?
|
| MEDLINE | 1 | 2008 | 20 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1642 | 0.080 |
Why?
|
| Myxoma | 2 | 1988 | 28 | 0.080 |
Why?
|
| Genotype | 2 | 2016 | 2542 | 0.080 |
Why?
|
| Coronary Restenosis | 1 | 2008 | 20 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2014 | 1541 | 0.080 |
Why?
|
| Triglycerides | 1 | 1991 | 562 | 0.080 |
Why?
|
| Long-Term Care | 2 | 2008 | 72 | 0.080 |
Why?
|
| Ventricular Remodeling | 1 | 2009 | 174 | 0.080 |
Why?
|
| Radiography | 10 | 1993 | 823 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2014 | 997 | 0.070 |
Why?
|
| Heart Neoplasms | 2 | 1988 | 100 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 793 | 0.070 |
Why?
|
| Vascular Patency | 1 | 2008 | 203 | 0.070 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2008 | 172 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 2839 | 0.070 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2009 | 274 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 1993 | 854 | 0.070 |
Why?
|
| Device Removal | 1 | 2008 | 222 | 0.070 |
Why?
|
| Prenatal Diagnosis | 1 | 2010 | 588 | 0.070 |
Why?
|
| Equipment Safety | 1 | 2005 | 37 | 0.060 |
Why?
|
| Heart | 5 | 1989 | 723 | 0.060 |
Why?
|
| Postoperative Complications | 4 | 1995 | 3014 | 0.060 |
Why?
|
| Diagnosis, Differential | 5 | 2001 | 1877 | 0.060 |
Why?
|
| Ultrasonography | 2 | 2012 | 940 | 0.060 |
Why?
|
| Prosthesis Design | 1 | 2008 | 672 | 0.060 |
Why?
|
| Down Syndrome | 3 | 2011 | 195 | 0.060 |
Why?
|
| Rhabdomyoma | 1 | 1984 | 16 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 451 | 0.060 |
Why?
|
| Prosthesis Implantation | 1 | 2005 | 143 | 0.060 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2005 | 85 | 0.060 |
Why?
|
| Thorax | 1 | 1984 | 72 | 0.060 |
Why?
|
| Prospective Studies | 8 | 2018 | 6040 | 0.060 |
Why?
|
| Safety | 1 | 2004 | 218 | 0.050 |
Why?
|
| Mitral Valve Prolapse | 2 | 1990 | 28 | 0.050 |
Why?
|
| Prevalence | 6 | 2012 | 2406 | 0.050 |
Why?
|
| Animals | 2 | 2015 | 33759 | 0.050 |
Why?
|
| Anorexia Nervosa | 1 | 1983 | 24 | 0.050 |
Why?
|
| Survival Analysis | 4 | 2000 | 1472 | 0.050 |
Why?
|
| Cholesterol, LDL | 3 | 1991 | 557 | 0.050 |
Why?
|
| Cardiac Output | 2 | 1981 | 169 | 0.050 |
Why?
|
| Aneurysm | 2 | 1986 | 88 | 0.050 |
Why?
|
| Referral and Consultation | 3 | 2014 | 529 | 0.050 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2002 | 51 | 0.050 |
Why?
|
| Mutation | 1 | 2015 | 5773 | 0.050 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2001 | 21 | 0.050 |
Why?
|
| Pulmonary Valve | 2 | 1980 | 94 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2001 | 391 | 0.050 |
Why?
|
| Tetralogy of Fallot | 4 | 1986 | 161 | 0.050 |
Why?
|
| Thallium | 1 | 1980 | 9 | 0.050 |
Why?
|
| Pain | 1 | 1984 | 470 | 0.050 |
Why?
|
| Zidovudine | 1 | 2000 | 22 | 0.050 |
Why?
|
| Coronary Circulation | 1 | 2001 | 209 | 0.040 |
Why?
|
| Linear Models | 2 | 2012 | 669 | 0.040 |
Why?
|
| Sinus of Valsalva | 1 | 1980 | 36 | 0.040 |
Why?
|
| Thermodilution | 1 | 1979 | 10 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2000 | 263 | 0.040 |
Why?
|
| Tolazoline | 1 | 1979 | 1 | 0.040 |
Why?
|
| Fetal Heart | 1 | 2000 | 111 | 0.040 |
Why?
|
| Echocardiography, Doppler | 1 | 2000 | 170 | 0.040 |
Why?
|
| Career Mobility | 1 | 2000 | 52 | 0.040 |
Why?
|
| Pulmonary Circulation | 2 | 1979 | 121 | 0.040 |
Why?
|
| Disease Progression | 3 | 2019 | 2025 | 0.040 |
Why?
|
| Job Satisfaction | 1 | 2000 | 78 | 0.040 |
Why?
|
| Physicians, Women | 1 | 2000 | 46 | 0.040 |
Why?
|
| Mediastinal Diseases | 1 | 1999 | 14 | 0.040 |
Why?
|
| Radionuclide Imaging | 5 | 1984 | 151 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 1979 | 104 | 0.040 |
Why?
|
| Corneal Opacity | 1 | 1998 | 23 | 0.040 |
Why?
|
| Gaucher Disease | 1 | 1998 | 12 | 0.040 |
Why?
|
| Aortic Aneurysm | 3 | 1989 | 224 | 0.040 |
Why?
|
| HIV-1 | 1 | 2002 | 465 | 0.040 |
Why?
|
| Cholesterol, HDL | 2 | 1991 | 348 | 0.040 |
Why?
|
| Cohort Studies | 5 | 2016 | 4710 | 0.040 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2011 | 795 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 1414 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 3546 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2000 | 228 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2004 | 753 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2000 | 444 | 0.040 |
Why?
|
| Anti-HIV Agents | 1 | 2000 | 306 | 0.040 |
Why?
|
| Incidence | 4 | 2012 | 3048 | 0.040 |
Why?
|
| Surgical Wound Infection | 1 | 1999 | 260 | 0.030 |
Why?
|
| Turner Syndrome | 1 | 1997 | 47 | 0.030 |
Why?
|
| Coronary Angiography | 4 | 2001 | 417 | 0.030 |
Why?
|
| Endocarditis, Bacterial | 2 | 1988 | 129 | 0.030 |
Why?
|
| Length of Stay | 2 | 2012 | 1284 | 0.030 |
Why?
|
| Pacemaker, Artificial | 2 | 1992 | 172 | 0.030 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 1999 | 252 | 0.030 |
Why?
|
| Morbidity | 1 | 2016 | 241 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2000 | 906 | 0.030 |
Why?
|
| Pericarditis | 2 | 1986 | 42 | 0.030 |
Why?
|
| Heart Septal Defects | 2 | 1985 | 40 | 0.030 |
Why?
|
| Competitive Behavior | 1 | 2014 | 10 | 0.030 |
Why?
|
| Preventive Medicine | 1 | 1994 | 22 | 0.030 |
Why?
|
| Autopsy | 2 | 1991 | 110 | 0.030 |
Why?
|
| Fetal Death | 1 | 1995 | 113 | 0.030 |
Why?
|
| Digoxin | 2 | 1987 | 41 | 0.030 |
Why?
|
| Health Services | 1 | 1994 | 71 | 0.030 |
Why?
|
| Sports | 1 | 2014 | 59 | 0.030 |
Why?
|
| Medically Underserved Area | 1 | 1994 | 92 | 0.030 |
Why?
|
| Actuarial Analysis | 1 | 1993 | 30 | 0.030 |
Why?
|
| Contraceptives, Oral | 1 | 1993 | 38 | 0.030 |
Why?
|
| Trachea | 2 | 1993 | 201 | 0.030 |
Why?
|
| Syndrome | 4 | 1983 | 1115 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 1998 | 507 | 0.030 |
Why?
|
| Pulmonary Valve Stenosis | 3 | 1984 | 40 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 1081 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 1994 | 117 | 0.030 |
Why?
|
| Internal Medicine | 1 | 1994 | 146 | 0.030 |
Why?
|
| Aorta | 1 | 1976 | 541 | 0.030 |
Why?
|
| Pneumococcal Infections | 1 | 1975 | 274 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 235 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 1994 | 299 | 0.030 |
Why?
|
| Mortality | 2 | 1984 | 228 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 2 | 1985 | 258 | 0.030 |
Why?
|
| International Normalized Ratio | 1 | 2012 | 42 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 1993 | 196 | 0.020 |
Why?
|
| Heart Septum | 2 | 1984 | 55 | 0.020 |
Why?
|
| Thromboembolism | 1 | 1992 | 84 | 0.020 |
Why?
|
| Polyarteritis Nodosa | 1 | 1991 | 7 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 1992 | 159 | 0.020 |
Why?
|
| Endocarditis | 1 | 1992 | 101 | 0.020 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1991 | 41 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 424 | 0.020 |
Why?
|
| Faculty, Medical | 1 | 2014 | 266 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 169 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 2830 | 0.020 |
Why?
|
| Heart Atria | 4 | 1984 | 311 | 0.020 |
Why?
|
| Diatrizoate Meglumine | 3 | 1986 | 18 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1008 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 1991 | 132 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2012 | 386 | 0.020 |
Why?
|
| Cysts | 1 | 1990 | 100 | 0.020 |
Why?
|
| Ebstein Anomaly | 1 | 1989 | 26 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2012 | 375 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 1243 | 0.020 |
Why?
|
| Calcinosis | 3 | 1998 | 170 | 0.020 |
Why?
|
| Aortic Coarctation | 2 | 1997 | 105 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1989 | 150 | 0.020 |
Why?
|
| Hodgkin Disease | 1 | 1991 | 293 | 0.020 |
Why?
|
| Haemophilus Infections | 1 | 1988 | 92 | 0.020 |
Why?
|
| Lovastatin | 1 | 1988 | 25 | 0.020 |
Why?
|
| Vena Cava, Superior | 2 | 1985 | 55 | 0.020 |
Why?
|
| Syncope | 1 | 1987 | 52 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2586 | 0.020 |
Why?
|
| Puerperal Disorders | 1 | 1987 | 46 | 0.020 |
Why?
|
| Scimitar Syndrome | 1 | 1987 | 52 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 1989 | 249 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2014 | 1070 | 0.020 |
Why?
|
| Thrombosis | 1 | 1991 | 520 | 0.020 |
Why?
|
| Computers | 2 | 1986 | 67 | 0.020 |
Why?
|
| Salmonella Infections | 1 | 1986 | 31 | 0.020 |
Why?
|
| Diuretics | 1 | 1987 | 158 | 0.020 |
Why?
|
| Renal Artery | 1 | 1986 | 74 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1987 | 218 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1987 | 233 | 0.020 |
Why?
|
| Endocarditis, Subacute Bacterial | 1 | 1985 | 1 | 0.020 |
Why?
|
| Phlebography | 1 | 1985 | 51 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1987 | 577 | 0.020 |
Why?
|
| Diatrizoate | 1 | 1984 | 3 | 0.010 |
Why?
|
| Exercise Test | 2 | 1983 | 249 | 0.010 |
Why?
|
| Tricuspid Valve | 1 | 1985 | 59 | 0.010 |
Why?
|
| Radiography, Thoracic | 2 | 1983 | 156 | 0.010 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1986 | 141 | 0.010 |
Why?
|
| Technetium | 2 | 1984 | 12 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1984 | 252 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 1991 | 823 | 0.010 |
Why?
|
| Sepsis | 1 | 1988 | 477 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1985 | 288 | 0.010 |
Why?
|
| Space-Time Clustering | 1 | 1983 | 1 | 0.010 |
Why?
|
| Telephone | 1 | 1984 | 110 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1984 | 270 | 0.010 |
Why?
|
| Ear, External | 1 | 1983 | 22 | 0.010 |
Why?
|
| Diet | 1 | 1990 | 1126 | 0.010 |
Why?
|
| Ohio | 1 | 1983 | 86 | 0.010 |
Why?
|
| Lens Subluxation | 1 | 2003 | 4 | 0.010 |
Why?
|
| Postoperative Period | 2 | 1986 | 330 | 0.010 |
Why?
|
| Postoperative Care | 2 | 1986 | 295 | 0.010 |
Why?
|
| Micrognathism | 1 | 1983 | 65 | 0.010 |
Why?
|
| Situs Inversus | 2 | 1979 | 25 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 849 | 0.010 |
Why?
|
| Life Tables | 1 | 2002 | 29 | 0.010 |
Why?
|
| Heart Rate | 2 | 2002 | 586 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 1987 | 478 | 0.010 |
Why?
|
| Organ Size | 1 | 2003 | 412 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 1982 | 68 | 0.010 |
Why?
|
| Seasons | 1 | 1983 | 303 | 0.010 |
Why?
|
| Preoperative Care | 2 | 1986 | 350 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 2001 | 17 | 0.010 |
Why?
|
| Cleft Palate | 1 | 1983 | 140 | 0.010 |
Why?
|
| Fistula | 1 | 1982 | 50 | 0.010 |
Why?
|
| ROC Curve | 1 | 2003 | 557 | 0.010 |
Why?
|
| Prostaglandins E | 1 | 1981 | 8 | 0.010 |
Why?
|
| Contrast Media | 1 | 1985 | 470 | 0.010 |
Why?
|
| Furosemide | 1 | 1981 | 36 | 0.010 |
Why?
|
| Alprostadil | 1 | 1981 | 27 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1980 | 38 | 0.010 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 1980 | 13 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2002 | 771 | 0.010 |
Why?
|
| Collateral Circulation | 1 | 1980 | 45 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1980 | 80 | 0.010 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 1982 | 89 | 0.010 |
Why?
|
| Observer Variation | 1 | 2001 | 296 | 0.010 |
Why?
|
| Microcephaly | 1 | 1983 | 328 | 0.010 |
Why?
|
| Mitochondria, Heart | 1 | 2000 | 60 | 0.010 |
Why?
|
| Risk | 1 | 2002 | 747 | 0.010 |
Why?
|
| Saphenous Vein | 1 | 1980 | 53 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 2000 | 69 | 0.010 |
Why?
|
| Pericardium | 1 | 1981 | 82 | 0.010 |
Why?
|
| Pyridoxal | 1 | 1979 | 1 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1980 | 297 | 0.010 |
Why?
|
| Glutamates | 1 | 1979 | 69 | 0.010 |
Why?
|
| HIV | 1 | 2000 | 179 | 0.010 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 1979 | 10 | 0.010 |
Why?
|
| Diving | 1 | 1979 | 3 | 0.010 |
Why?
|
| Tachycardia | 1 | 1999 | 68 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2000 | 260 | 0.010 |
Why?
|
| Pericardial Effusion | 1 | 1999 | 64 | 0.010 |
Why?
|
| Maternal Exposure | 1 | 2000 | 148 | 0.010 |
Why?
|
| Sternum | 1 | 1999 | 53 | 0.010 |
Why?
|
| Hypoxia | 1 | 1981 | 247 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2000 | 450 | 0.010 |
Why?
|
| Debridement | 1 | 1999 | 85 | 0.010 |
Why?
|
| Spleen | 1 | 1979 | 272 | 0.010 |
Why?
|
| AIDS Dementia Complex | 1 | 1998 | 12 | 0.010 |
Why?
|
| Myocardium | 1 | 2003 | 984 | 0.010 |
Why?
|
| Corneal Stroma | 1 | 1998 | 90 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 2026 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1998 | 230 | 0.010 |
Why?
|
| Prenatal Care | 1 | 2000 | 343 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2000 | 600 | 0.010 |
Why?
|
| Diet, Fat-Restricted | 1 | 1997 | 42 | 0.010 |
Why?
|
| Health Maintenance Organizations | 1 | 1997 | 22 | 0.010 |
Why?
|
| Polyethylene Terephthalates | 1 | 1976 | 40 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 1984 | 1000 | 0.010 |
Why?
|
| Heart Sounds | 1 | 1976 | 9 | 0.010 |
Why?
|
| Gestational Age | 1 | 2000 | 1138 | 0.010 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 1997 | 174 | 0.010 |
Why?
|
| Kanamycin | 1 | 1975 | 6 | 0.010 |
Why?
|
| Nafcillin | 1 | 1975 | 14 | 0.010 |
Why?
|
| Penicillin G | 1 | 1975 | 19 | 0.010 |
Why?
|
| Lung Diseases | 1 | 1979 | 385 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 1975 | 47 | 0.010 |
Why?
|
| Counseling | 1 | 1997 | 219 | 0.010 |
Why?
|
| Glucose | 1 | 1979 | 872 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1976 | 659 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1988 | 1151 | 0.010 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1976 | 533 | 0.010 |
Why?
|
| Heart Murmurs | 1 | 1990 | 15 | 0.010 |
Why?
|
| Necrosis | 1 | 1990 | 205 | 0.010 |
Why?
|
| Heart Valves | 1 | 1990 | 51 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 1989 | 93 | 0.010 |
Why?
|
| Emergencies | 1 | 1990 | 174 | 0.000 |
Why?
|
| Colestipol | 1 | 1988 | 6 | 0.000 |
Why?
|
| Stroke Volume | 1 | 1989 | 445 | 0.000 |
Why?
|
| Methods | 2 | 1977 | 147 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1991 | 325 | 0.000 |
Why?
|
| Aortic Arch Syndromes | 1 | 1986 | 11 | 0.000 |
Why?
|
| Manometry | 1 | 1986 | 48 | 0.000 |
Why?
|
| Salmonella typhimurium | 1 | 1986 | 42 | 0.000 |
Why?
|
| Renal Veins | 1 | 1986 | 35 | 0.000 |
Why?
|
| Esophagoscopy | 1 | 1986 | 156 | 0.000 |
Why?
|
| Esophagus | 1 | 1986 | 213 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 1987 | 501 | 0.000 |
Why?
|
| Rheumatic Heart Disease | 1 | 1985 | 37 | 0.000 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1986 | 175 | 0.000 |
Why?
|
| Premedication | 1 | 1983 | 43 | 0.000 |
Why?
|
| Heart Function Tests | 1 | 1983 | 56 | 0.000 |
Why?
|
| Bundle of His | 1 | 1982 | 7 | 0.000 |
Why?
|
| Diseases in Twins | 1 | 1982 | 94 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1985 | 1239 | 0.000 |
Why?
|
| Gallbladder | 1 | 1979 | 19 | 0.000 |
Why?
|
| Truncus Arteriosus | 1 | 1979 | 13 | 0.000 |
Why?
|
| Minnesota | 1 | 1977 | 132 | 0.000 |
Why?
|
| Pressure | 1 | 1977 | 130 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1985 | 2058 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1985 | 2394 | 0.000 |
Why?
|
| Liver | 1 | 1979 | 1734 | 0.000 |
Why?
|